Skip to main content
Journal of Cachexia, Sarcopenia and Muscle logoLink to Journal of Cachexia, Sarcopenia and Muscle
. 2023 Jan 25;14(2):1142. doi: 10.1002/jcsm.13172

Corrigendum to Takagi et al. J Cachexia Sarcopenia Muscle, 13, 287‐295. https://doi.org/10.1002/jcsm.12906

PMCID: PMC10067475  PMID: 36697263

In Table 3, the details under the ‘Variable’ column are incorrect. Under the section ‘Sarcopenia’, ‘with sarcopenia group (n = 57)’ and ‘without sarcopenia group (n = 57)’ should have been swapped.

TABLE 3.

Association of carnitine levels with sarcopenia, nutrition status, surgical outcome

Variable TC FC AC
Sarcopenia P = 0.0124 P = 0.0243 P = 0.102
Without sarcopenia group ( n  = 57) 63.3 (29–102.5) 52.2 (24.8–93.5) 11 (4.2–24.5)
With sarcopenia group (n = 57) 56.6 (25.5–91.2) 46.8 (20.6–77.2) 9.8 (3.9–18.9)
Nutrition status a P = 0.0003 P = 0.0001 P = 0.484
Low PNI group (n = 66) 54.3 (25.5–90.8) 44.2 (20.6–69.5) 10.2 (3.9–20.4)
High PNI group (n = 48) 64 (38–102.5) 53.4 (29.4–93.5) 10.7 (4.7–19.1)
Surgical outcome P = 0.997 P = 0.872 P = 0.411
With postoperative complication (n = 37) 59.9 (32–90.8) 49.2 (22.8–77.2) 10.9 (5.4–24.5)
Without postoperative complication (n = 77) 59.9 (25.5–102.5) 49.6 (20.6–93.5) 10.2 (3.9–20.4)

AC, acylcarnitine FC, free carnitine; PNI, prognostic nutritional index; TC, total carnitine.

a

Cut‐off value is mean PNI value.

The correct details are highlighted in red as shown in the updated Table 3 below:


Articles from Journal of Cachexia, Sarcopenia and Muscle are provided here courtesy of Wiley

RESOURCES